InsiderTrades

Form 4 for MGNX MACROGENICS INC

Accepted 2023-02-24 00:00:00 ET · period of report 2023-02-22 · accession 0001125345-23-000040 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-02-24 2023-02-22 MGNX Bonvini Ezio SVP, CSO, Research F - Tax $6.55 -3,619 120.2K -3% -$23.7K
D 2023-02-24 2023-02-22 MGNX Bonvini Ezio SVP, CSO, Research M - OptEx $0.00 +9,375 123.8K +8% $0
D 2023-02-24 2023-02-22 MGNX Bonvini Ezio SVP, CSO, Research M - OptEx $0.00 -9,375 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-02-22 F D 3,619 $6.55 120,180 D — —
2 Common Common Stock 2023-02-22 M A 9,375 $0.00 123,799 D — — (F1) On February 22, 2022 the reporting person was granted 37,500 restricted stock units, 25% of which vested on February 22, 2023 and 75% of which will vest two years after the date of grant. Restricted stock units convert into the Company's stock on a one-for-one basis.
3 Derivative Restricted Stock Unit 2023-02-22 M D 9,375 $0.00 0 D $0.00 · — to — 9,375 Common Stock (F1) On February 22, 2022 the reporting person was granted 37,500 restricted stock units, 25% of which vested on February 22, 2023 and 75% of which will vest two years after the date of grant. Restricted stock units convert into the Company's stock on a one-for-one basis.